Conflict Of Interest
They receive significant funding and industry reps sit on their boards
IVF companies in Australia have come under fire following a Four Corners investigation.
The widely prescribed anti-depressant Paxil has been found by researchers to be neither safe nor effective for the treatment of depression.
Couples are usually unaware of the low IVF success rates in Australian clinics.
Should we always blame the journalist for poor science reporting? Perhaps not, according to a new BMJ study.
Aaron E. Carroll, a blogger at The Incidental Economist, summarises recent research about conflicts of interest.
A new survey of North Carolina doctors has found that many are concerned about the increasing number of requests they are receiving to assess their patients' competency to carry concealed weapons. In particular, a majority of physicians who responded to the survey said they were worried about the potential ethical consequences in the doctor-patient relationship if they participated in the concealed-weapon permit process.
A lawsuit against the medical products giant Johnson & Johnson has raised questions about doctors’ willingness to warn colleagues and patients about bad drugs or devices.
The US Senate's Finance Committee has asked seven organisations, including the well-known Center for Practical Bioethics, in Kansas City, for information about financial ties to the pharmaceutical industry.
Gadfly: a person who annoys or criticizes others in order to provoke them into action. There is no better word to describe Carl Elliott, a University of Minnesota bioethicist who is the profession’s most savage critic. In his column in the Chronicle of Higher Education this week, he took up a favourite theme: cosying up to the pharmaceutical industry. He complains that too many bioethicists are being funded by Big Pharma, which Dr Elliott tends to describe as a Mafia network.
"Enough. I resigned from #Celltex Therapeutics on & effective 2/28/2012. I am preparing timely, lengthy, pointed comments on the whole matter." This is a Tweet this week from Glenn McGee, the embattled bioethicist who moved from the American Journal of Bioethics (AJOB) to a stem cell company in Texas.
The latest conflict between bioethical purists and bioethical pragmatists concerns the former editor of the American Journal of Bioethics, Glenn McGee. Dr McGee founded and nurtured AJOB until it now has the highest impact factor in its field (3.986 in 2010). In the AJOB stable are a website and two other journals, AJOB Neuroscience and AJOB Primary Research. He has been a controversial character, but nothing has kicked up controversy so much as the circumstances surrounding his departure.